{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:58Z","timestamp":1753891318517,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Over the last several decades, our understanding of hidradenitis suppurativa (HS) has improved considerably, thereby enhancing our ability to clinically diagnose and treat the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this study was to identify and analyze the top 100 most-cited publications related to HS to update bibliometric information on HS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We used the Web of Science database to identify reports on hidradenitis suppurativa. Data from the 100 most-cited publications were extracted and analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The citation number of the top 100 most-cited articles was 89\u2013532 (mean, 153.51), with the most productive periods being from years 2007 to 2016. Most publications originated from the <jats:italic>British Journal of Dermatology<\/jats:italic> and the <jats:italic>Journal of the American Academy of Dermatology<\/jats:italic>. The 100 articles originated from 18 countries, with Denmark being the most productive country, followed by the United States (17), England (14), and Germany (12). Jemec GB, from the University of Copenhagen, had 32 citations and was the most frequently identified author. The 100 articles encompassed several fields of research as follows: pathogenesis (18%), pathophysiology (7%), epidemiology (14%), clinical diagnosis and features (16%), treatment (25%), comorbidity (10%), and others (10%). In total, 11 reviews, three guidelines, and 86 original articles (nine randomized clinical trials) were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Through this bibliometric analysis, we aimed to indicate a series of intellectual landmark publications that offer us critical reviews, guidelines, and original articles, which highlight the immense level of progress achieved in the field of HS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.995873","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T09:39:10Z","timestamp":1662629950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Top 100 most-cited publications in hidradenitis suppurativa: An updated bibliometric analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Yan","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"Hidradenitis suppurativa\u201d is acne inversa! An appeal to (finally) abandon a misnomer.","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.02872.x","article-title":"Hidradenitis suppurativa is acne inversa.","volume":"46","author":"Bazex","year":"2010","journal-title":"Int J Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.","volume":"21","author":"van derZee","year":"2012","journal-title":"Exp Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis suppurativa.","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11948-015-9638-0","article-title":"Evaluation by citation: trends in publication behavior, evaluation criteria, and the strive for high impact publications.","volume":"22","author":"van Wesel","year":"2016","journal-title":"Sci Eng Ethics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/ijd.14261","article-title":"The 100 top-cited publications in psoriatic arthritis: a bibliometric analysis.","volume":"58","author":"Berlinberg","year":"2018","journal-title":"Int J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/jdv.16305","article-title":"The Top 100 most cited articles in rosacea: a bibliometric analysis.","volume":"34","author":"Wang","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/DSS.0000000000000134","article-title":"100 citation classics in the melanoma literature: a bibliometric analysis.","volume":"40","author":"Joyce","year":"2014","journal-title":"Dermatol Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/DSS.0000000000003251","article-title":"Merkel cell carcinoma: A bibliometric analysis of the top 100 cited publications.","volume":"48","author":"Russomanno","year":"2022","journal-title":"Dermatol Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000513771","article-title":"Bibliometric analysis of the 50 most cited publications in hidradenitis suppurativa.","volume":"7","author":"Seivright","year":"2021","journal-title":"Skin Appendage Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa.","volume":"34","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae.","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa.","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.","volume":"672","author":"Nazary","year":"2011","journal-title":"Eur J Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review.","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies.","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.","volume":"161","author":"Sartorius","year":"2010","journal-title":"Br J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa.","volume":"198","author":"Konig","year":"1999","journal-title":"Dermatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1183\/09031936.00062209","article-title":"Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor.","volume":"36","author":"Mortaz","year":"2010","journal-title":"Eur Respir J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa.","volume":"150","author":"Marie","year":"2014","journal-title":"JAMA Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.","volume":"173","author":"Tzellos","year":"2016","journal-title":"Br J Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa.","volume":"27","author":"Onderijk","year":"2012","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.","volume":"40","author":"Boer","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00006254-198710000-00018","article-title":"A Double-Blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.","volume":"42","author":"Mortimer","year":"1987","journal-title":"Obstet Gynecol Survey."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way.","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two Phase 3 trials of adalimumab for hidradenitis suppurativa.","volume":"375","author":"Kimball","year":"2016","journal-title":"New Engl J Med."},{"key":"B30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.7326\/0003-4819-159-1-201307020-00016","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.","volume":"159","author":"Kimball","year":"2013","journal-title":"Ann Int Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa.","volume":"26","author":"Rompel","year":"2010","journal-title":"Dermatol Surg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","article-title":"Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.","volume":"63","author":"van der Zee","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/bmj.294.6570.487","article-title":"Recurrence after surgical treatment of hidradenitis suppurativa.","volume":"294","author":"Harrison","year":"1987","journal-title":"Br Med J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa.","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.995873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T09:39:13Z","timestamp":1662629953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.995873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":37,"alternative-id":["10.3389\/fmed.2022.995873"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.995873","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"995873"}}